Zipf W B, O'Dorisio T M, Berntson G G
Department of Pediatrics, Children's Hospital, Columbus, OH 43205.
Am J Clin Nutr. 1990 Feb;51(2):162-6. doi: 10.1093/ajcn/51.2.162.
Ten children with Prader-Willi syndrome (PWS) were given two 90-min infusions of pancreatic polypeptide (PP) (100 pmol.kg-1.h-1) counterbalanced with two saline infusions. Thirty minutes into each infusion, a 60-min appetite test was given. Tests were done after an overnight fast and 1 h after a 275-kcal breakfast meal. Serum assays for biochemistry, glucose, insulin, C peptide, glucagon, cortisol, and PP were performed at the beginning and end of the infusion. Although infusion of PP increased PP concentrations 10-fold, it did not cause physical signs or symptoms, changes in vital signs, or changes in serum biochemistry. Although the test design was sufficiently sensitive to reveal an effect of the pretest meal on subsequent food intake, there was no difference in eating behavior with the saline and PP infusions. This suggests that a short-term normalization of blood PP concentrations does not correct the excessive food intake.
对10名普拉德-威利综合征(PWS)患儿进行了两次90分钟的胰多肽(PP)输注(100 pmol·kg⁻¹·h⁻¹),并与两次生理盐水输注进行平衡对照。每次输注30分钟后,进行一次60分钟的食欲测试。测试在禁食过夜后以及进食275千卡早餐1小时后进行。在输注开始和结束时进行血清生化、葡萄糖、胰岛素、C肽、胰高血糖素、皮质醇和PP的检测。尽管输注PP使PP浓度增加了10倍,但未引起体征或症状、生命体征变化或血清生化改变。尽管测试设计足够灵敏以揭示测试前一餐对后续食物摄入量的影响,但生理盐水输注和PP输注时的进食行为并无差异。这表明血液PP浓度的短期正常化并不能纠正过度的食物摄入。